Free Trial

BI Asset Management Fondsmaeglerselskab A S Sells 21,384 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Crescent Capital BDC logo with Finance background

BI Asset Management Fondsmaeglerselskab A S lowered its stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 31.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,815 shares of the company's stock after selling 21,384 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S owned 0.12% of Crescent Capital BDC worth $881,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Franklin Resources Inc. grew its stake in Crescent Capital BDC by 12.8% in the fourth quarter. Franklin Resources Inc. now owns 289,131 shares of the company's stock valued at $5,557,000 after acquiring an additional 32,852 shares during the period. Condor Capital Management lifted its holdings in shares of Crescent Capital BDC by 4.7% in the 4th quarter. Condor Capital Management now owns 284,055 shares of the company's stock worth $5,460,000 after purchasing an additional 12,852 shares in the last quarter. Wells Fargo & Company MN grew its position in Crescent Capital BDC by 0.5% in the 4th quarter. Wells Fargo & Company MN now owns 253,182 shares of the company's stock valued at $4,866,000 after purchasing an additional 1,210 shares during the period. Raymond James Financial Inc. acquired a new stake in Crescent Capital BDC in the 4th quarter valued at $3,750,000. Finally, Denali Advisors LLC increased its stake in Crescent Capital BDC by 0.5% during the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company's stock valued at $3,532,000 after purchasing an additional 855 shares in the last quarter. Institutional investors and hedge funds own 49.46% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CCAP shares. Keefe, Bruyette & Woods reduced their price objective on shares of Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating for the company in a report on Tuesday, April 8th. Wells Fargo & Company cut their price target on Crescent Capital BDC from $18.00 to $16.00 and set an "equal weight" rating for the company in a research note on Monday. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $18.50.

Read Our Latest Stock Report on CCAP

Crescent Capital BDC Stock Down 1.2 %

Shares of NASDAQ CCAP traded down $0.19 during trading on Tuesday, hitting $16.05. The stock had a trading volume of 16,170 shares, compared to its average volume of 142,688. The firm has a fifty day moving average of $16.71 and a two-hundred day moving average of $18.31. The company has a market capitalization of $594.85 million, a PE ratio of 8.04 and a beta of 0.56. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. Crescent Capital BDC, Inc. has a 12 month low of $13.54 and a 12 month high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The firm had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. As a group, equities research analysts forecast that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently declared a dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a dividend of $0.05 per share. The ex-dividend date was Friday, February 28th. Crescent Capital BDC's dividend payout ratio (DPR) is currently 84.42%.

Crescent Capital BDC Company Profile

(Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Institutional Ownership by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines